MIGRAINE AND HEADACHE RELIEF AT THE SPEED OF LIGHT. New Technology Has FDA And Patient Approval.

(PRLEAP.COM) People suffering from migraine headaches and/or tension headaches no longer need to rely on medication for relief. New FDA approved Cold Laser treatment is having tremendous success with reducing and eliminating chronic headache symptoms. According to the North American Association of Laser Therapy (NAALT), cold laser therapy has above an 80% success with multiple ailments. The treatment can significantly reduce the pain and symptoms associated with this condition.

The concept of cold laser has been around for over 25-30 years mainly in Europe and has been used to treat multiple injuries ranging from carpal tunnel syndrome to headaches. During cold laser treatment, a high wavelength light is passed through the injured area and causes an increase in cell metabolism in the area. This increased cell synthesis causes an increased immune system response, which in turn effectively increases the healing of the injured tissue.

The mission of the NAALT is to improve understanding of the photo biological mechanisms, basic laser physics, treatment parameters, techniques, and regulatory issues.

Dr. Vishal Verma, D.C., a member of the NAALT, states that “cold laser therapy has become the leader in headache pain relief and is supported by the research”.
Contact Information

About This News Release

If you have any questions regarding information in these press releases please contact the organization listed in the press release. Issuers of press releases and not PR Leap are solely responsible for the accuracy of the content.

Your News Online

Over 30,000 companies use PR LEAP
PR LEAP offers an SEO and Social Media press release distribution service that is more affordable than the top 3 wires. Our member's press releases can be found on Google News, Google Search, Yahoo!, MSN, Ask.com News, Ask.com, Topix.net and many more.

Pricing & Signup

PR Leap is a service of Condesa, Inc. © 2007 All Rights Reserved. Use of our service is governed by our Privacy Policy and Terms of Service.
Issuers of news releases are solely responsible for the accuracy of their content. Copyright / IP Policy